A drugmaker working to develop a pill to boost sexual desire in women says regulators are demanding more studies on the experimental drug.
(HealthDay)—Naproxen—the key pain reliever in Aleve—seems safer for the heart than other popular anti-inflammatory drugs such as ibuprofen (Advil and Motrin), U.S. health officials say.
The Food and Drug Administration is warning against eating Uncle Ben's rice products served at schools, restaurants, hospitals and other food service institutions after children in three states had skin reactions and other ...
The Food and Drug Administration is laying out new requirements to ensure the safety of infant formula.
America's large food companies are trying to head off efforts to enact mandatory labeling of genetically modified ingredients by proposing new voluntary labels nationwide.
Ranbaxy Laboratories, India's biggest generic drugmaker by sales, reported a narrower quarterly loss on Wednesday thanks to rising sales in key markets and currency gains.
Merck & Co. says it's won its first approval for its new immunotherapy tablet for grass allergies, from regulators in Canada.
A kinder, gentler approach to one of the most dreaded exams in medicine is on the way: U.S. regulators have cleared a bite-size camera to help screen patients who have trouble with colonoscopies.
US federal regulators said Friday they were investigating products containing testosterone after recent studies suggested a higher risk of strokes and heart attacks in men being treated with the hormone.
The Food and Drug Administration is proposing new rules to keep food safe while it's transported.
U.S. health regulators have approved a first-of-a-kind drug to treat a sleep disorder that mainly afflicts the blind.
Federal health experts say the pain reliever found in Aleve may be safer on the heart than other popular anti-inflammatory drugs taken by millions of Americans.
Shares in one of India's biggest drugmakers, Ranbaxy Laboratories, slid 19 percent Friday after the US Food and Drug Administration suspended imports from a fourth manufacturing plant of the firm.
U.S. health regulators said Thursday they are barring imported drugs from an overseas factory operated by Ranbaxy Laboratories, India's largest drugmaker, due to quality control violations.
Those nutrition labels on the back of food packages may soon become easier to read.